Company / Shareholders' Equity
Mettler Toledo Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$23.6M
FY2025
5-year range
-$149.9M / $420.8M
FY2021-FY2025
Trend
+81.4%
vs FY2024
Sector context
#152 of 161
Health Care
What the data says
Mettler Toledo reports negative total equity of -$24M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$24M in FY2025.
Improved from -$150M to -$24M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 161This company -$23.6M Sector average $5.1B
▼
-100.5% below sector average
Key checks
Key Insights
- In FY2025, shareholders' equity increased 81.4% year-over-year.
- Ranks #152 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2020.
- Lowest shareholders' equity in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.22 (safe zone, above 2.9 threshold)
- Strong profit margin: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$23.6M | +81.4% |
| FY2024 | -$126.9M | +15.4% |
| FY2023 | -$149.9M | -153.0% |
| FY2022 | $282.7M | -32.8% |
| FY2021 | $420.8M | -28.7% |
| FY2020 | $590.1M | +7.8% |
| FY2019 | $547.3M | -7.3% |
| FY2018 | $590.1M | +7.8% |
| FY2017 | $547.3M | +25.8% |
| FY2016 | $434.9M | -25.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026